| 2211 |
PANSOL |
FLURBIPROFEN 100 MG |
TABLET |
BLISTERPACK |
PANOSAL IS INDICATED IN ANKYLOSING SPONDYLITIS, DYSMENORRHOOEA, GOUT, JUVENILE CHRONIC ARTHRITIS, MILD TO MODERATE PAIN, MUSCULOSKELETAL DISORDERS, PALLIATIVE CARE, OSTEOARTHRITIS PAIN, POST OPERATIVE ANALGESIA, RHEUMATOID ARTHRITIS, DENTAL PAIN. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4187/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
| 2212 |
POLYROLE |
IRON III HYDROXIDE POLYMALTOSE COMPLAX EQ. ELEMENTAL IRON 100 MG
FOLIC ACID 0.35 MG |
TABLET |
BLISTERPACK |
TREATMENT OF ALL KINDS OF THE IRON DEFICIENCY PARTICULARLY IRON DEFICIENCY ANEMIA. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4192/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
| 2213 |
RANCARD XR TABLET 1000 MG |
RANOLAZINE 1000 MG |
TABLET |
ALU-ALU BLISTER |
INDICATED IN ADULT AS ADD-ON THERAPY FOR THE SYMPTOMATIC TREATMENT OF PATIENTS WITH STABLE ANGINA PECTORIS WHO ARE INDADEQUATELY CONTROLLED OR INTOLERANT TO FIRSTLINE ANTI-ANGINAL THERAPIES(SUCH AS BETA BLOCKERS AND/OR CALCIUM ANTAGONIST) |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
05 I 5510/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
| 2214 |
RANCARD XR TABLET 500 MG |
RANOLAZINE 500 MG |
TABLET |
ALU-ALU BLISTER |
INDICATED IN ADULT AS ADD-ON THERAPY FOR THE SYMPTOMATIC TREATMENT OF PATIENTS WITH STABLE ANGINA PECTORIS WHO ARE INDADEQUATELY CONTROLLED OR INTOLERANT TO FIRSTLINE ANTI-ANGINAL THERAPIES(SUCH AS BETA BLOCKERS AND/OR CALCIUM ANTAGONIST) |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
05 I 5511/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
| 2215 |
RELISPA FORTE TABLETS |
DROTAVERINE HCL 80 MG |
TABLET |
ALU-ALU BLISTER |
FOR SYMTOMATIC RELIEF OF SPASM IN INTESTINAL COLIC, BILIARY COLIC, URETERIC COLIC AND DYSMENORRHEA, IT IS ADVOCATED TO PREVENT PREMATURE LABOR AT TERM ANS ALSO TO AUGMENT LABOR WHILST LOWERING THE INCIDENC OF CERVICAL RUPTURE. |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
05 I 5531/23 |
15-MAY-2023 |
14-MAY-2026 |
View |
| 2216 |
RELISPA TABLETS |
DROTAVERINE HCL 40 MG |
TABLET |
ALU-ALU BLISTER |
FOR SYMTOMATIC RELIEF OF SPASM IN INTESTINAL COLIC, BILIARY COLIC, URETERIC COLIC AND DYSMENORRHEA, IT IS ADVOCATED TO PREVENT PREMATURE LABOR AT TERM ANS ALSO TO AUGMENT LABOR WHILST LOWERING THE INCIDENC OF CERVICAL RUPTURE. |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
05 I 5533/23 |
15-MAY-2023 |
14-MAY-2026 |
View |
| 2217 |
RELISPA INJECTION |
DROTAVERINE HCL 40 MG/ 2ML |
SOLUTION FOR INJECTION |
AMPOULES |
FOR SYMTOMATIC RELIEF OF SPASM IN INTESTINAL COLIC, BILIARY COLIC, URETERIC COLIC AND DYSMENORRHEA, IT IS ADVOCATED TO PREVENT PREMATURE LABOR AT TERM ANS ALSO TO AUGMENT LABOR WHILST LOWERING THE INCIDENC OF CERVICAL RUPTURE. |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
05 I 5532/23 |
15-MAY-2023 |
14-MAY-2026 |
View |
| 2218 |
SEA-MOX TABLETS 400 MG |
MOXIFLOXACIN (AS HYDROCHLORIDE) 400 MG |
TABLETS
|
ALU-ALU BLISTER |
INDICATED FOR TREATMENT OFTHE FOLLOWING BACTERIAL INFECTIONS IN PATIENTS OF 18 YEARS OF AGE AND OLDER CAUSED BY BACTERIA SUCEPTIBLE TO MOXIFLOXACIN: ACUTE BACTERIA SINUSITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, COMMUNITY ACQUIRED PNEUMONIA, EXCEPT SEVERE CASES, MILD TO MODERATE PELVIC INFLAMMATORY DISEASE, COMMUNITY-ACQUIRED PNEUMONIA, COMPLICATED SKIN AND SKIN STRUCTURE INFECTION |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
05 I 5534/23 |
15-MAY-2023 |
14-MAY-2026 |
View |
| 2219 |
TELESTA TABLETS 20 MG |
TELMISARTAN 20 MG |
TABLETS |
ALU-ALU BLISTER |
TREATMENT OF ESSENTIAL HYPERTENSION AND CARDIOVASCULAR PREVENTION |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
06 I 5766/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
| 2220 |
TELESTA TABLETS 40 MG |
TELMISARTAN 40 MG |
TABLETS |
ALU-ALU BLISTER |
TREATMENT OF ESSENTIAL HYPERTENSION AND CARDIOVASCULAR PREVENTION |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
06 I 5767/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
